KAI FU, MD, PHD
Medical Practice at Nebraska Medical Ctr, Omaha, NE
License number
Nebraska 21976
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
988102 Nebraska Medical Ctr, Omaha, NE 68198
Phone
(402) 559-4186
(402) 559-6018 (Fax)
(402) 559-6018 (Fax)
Personal information
See more information about KAI FU at radaris.comName
Address
Phone
3878 S 175Th Ave, Omaha, NE 68130
15909 Bancroft Ct APT 821, Omaha, NE 68130
Omaha, NE
983235 Nebraska Medical Ctr, Omaha, NE 68198
15909 Bancroft St, Omaha, NE 68130
Organization information
See more information about KAI FU at bizstanding.comUniversity Of Nebraska Medical Center - Kai Fu MD
983135 Nebraska Medical Ctr, Omaha, NE 68198
Categories:
Pathology Physicians & Surgeons
Phone:
(402) 559-4186 (Phone)
Professional information
See more information about KAI FU at trustoria.com
Associated Professor At University Of Nebraska Medical Center
Associated Professor At University Of Nebraska Medical Center
Position:
Associate Professor at University of Nebraska Medical Center
Location:
Greater Omaha Area
Industry:
Higher Education
Work:
University of Nebraska Medical Center
since Jul 2004
-
Associate Professor
Education:
University of Kansas School of Medicine 1992 - 1997
Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology Tianjin Medical University 1985 - 1990
Doctor of Medicine (M.D.), Medicine Nankai University 1982 - 1985
Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology Tianjin Medical University 1985 - 1990
Doctor of Medicine (M.D.), Medicine Nankai University 1982 - 1985
Kai Fu, Omaha NE
Kai Fu, Omaha NE
Specialties:
Pathologist
Address:
988102 Nebraska Medical Ctr, Omaha, NE 68198
Omaha, NE 68198
Omaha, NE 68198
Board certifications:
American Board of Pathology Certification in Clinical Pathology (Pathology), American Board of Pathology Sub-certificate in Hematology (Pathology)
Dr. Kai Fu - MD (Doctor of Medicine)
Dr. Kai Fu - MD (Doctor of Medicine)
Hospitals:
Univ Nebraska Med Ctr Pathology
983135 Nebraska Medical Ctr SUITE 3506, Omaha 68198
Nebraska Orthopaedic Hospital
2808 South 143Rd Plz, Omaha 68144
Univ Nebraska Med Ctr Pathology
983135 Nebraska Medical Ctr SUITE 3506, Omaha 68198
Nebraska Orthopaedic Hospital
2808 South 143Rd Plz, Omaha 68144
983135 Nebraska Medical Ctr SUITE 3506, Omaha 68198
Nebraska Orthopaedic Hospital
2808 South 143Rd Plz, Omaha 68144
Univ Nebraska Med Ctr Pathology
983135 Nebraska Medical Ctr SUITE 3506, Omaha 68198
Nebraska Orthopaedic Hospital
2808 South 143Rd Plz, Omaha 68144
Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas
Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas
US Patent:
2012022, Sep 6, 2012
Filed:
Mar 1, 2012
Appl. No.:
13/409416
Inventors:
Louis M. Staudt - Silver Spring MD, US
George Wright - Rockville MD, US
Sandeep Dave - Washington DC, US
Bruce Tan - Baltimore MD, US
John I. Powell - Ijamsville MD, US
Wyndham Wilson - Washington DC, US
Elaine Jaffe - Great Falls VA, US
Wing C. Chan - Omaha NE, US
Timothy C. Greiner - Council Bluffs IA, US
Dennis Weisenburger - Elkhorn NE, US
James Armitage - Omaha NE, US
Kai Fu - Omaha NE, US
Richard I. Fisher - Pittsford NY, US
Lisa Rimsza - Tucson AZ, US
Thomas Miller - Tucson AZ, US
Thomas Grogan - Tucson AZ, US
Elias Campo - Barcelona, ES
Silvia M. Bea - Sabadell, ES
Itziar Salaverria - Barcelona, ES
Armando Lopez-Guillermo - Barcelona, ES
Emili Montserrat - Barcelona, ES
Victor Moreno - Barcelona, ES
Andreas Zetti - Wurzburg, DE
German Ott - Wurzburg, DE
Hans-Konrad Muller-Hermelink - Wuerzburg, DE
Andreas Rosenwald - Wuerzburg, DE
Julie Vose - Omaha NE, US
Randy Gascoyne - North Vancouver, CA
Joseph Connors - Vancouver, CA
Erlend Smeland - Oslo, NO
Stein Kvaloy - Oslo, NO
Harald Holte - Oslo, NO
Jan Delabie - Oslo, NO
T. Andrew Lister - London, GB
George Wright - Rockville MD, US
Sandeep Dave - Washington DC, US
Bruce Tan - Baltimore MD, US
John I. Powell - Ijamsville MD, US
Wyndham Wilson - Washington DC, US
Elaine Jaffe - Great Falls VA, US
Wing C. Chan - Omaha NE, US
Timothy C. Greiner - Council Bluffs IA, US
Dennis Weisenburger - Elkhorn NE, US
James Armitage - Omaha NE, US
Kai Fu - Omaha NE, US
Richard I. Fisher - Pittsford NY, US
Lisa Rimsza - Tucson AZ, US
Thomas Miller - Tucson AZ, US
Thomas Grogan - Tucson AZ, US
Elias Campo - Barcelona, ES
Silvia M. Bea - Sabadell, ES
Itziar Salaverria - Barcelona, ES
Armando Lopez-Guillermo - Barcelona, ES
Emili Montserrat - Barcelona, ES
Victor Moreno - Barcelona, ES
Andreas Zetti - Wurzburg, DE
German Ott - Wurzburg, DE
Hans-Konrad Muller-Hermelink - Wuerzburg, DE
Andreas Rosenwald - Wuerzburg, DE
Julie Vose - Omaha NE, US
Randy Gascoyne - North Vancouver, CA
Joseph Connors - Vancouver, CA
Erlend Smeland - Oslo, NO
Stein Kvaloy - Oslo, NO
Harald Holte - Oslo, NO
Jan Delabie - Oslo, NO
T. Andrew Lister - London, GB
Assignee:
The United States of America, as Represented by the Secretary, Dept. of Health and Human Services - Bethesda MD
Board of Regents of the University of Nebraska - Lincoln NE
University of Rochester - Rochester NY
Arizona Board of Regents on Behalf of the University of Arizona - Tucson AZ
Universitat De Barcelona - Barcelona
Queen Mary and Westfield College, University of London - London
Hospital Clinic - Barcelona
Julius-Maximilians-University of Wuerzburg - Wrzburg
British Columbia Cancer Agency Branch - Vancover
Oslo University Hospital HE - Oslo
Fundacio Clinic - Barcelona
Board of Regents of the University of Nebraska - Lincoln NE
University of Rochester - Rochester NY
Arizona Board of Regents on Behalf of the University of Arizona - Tucson AZ
Universitat De Barcelona - Barcelona
Queen Mary and Westfield College, University of London - London
Hospital Clinic - Barcelona
Julius-Maximilians-University of Wuerzburg - Wrzburg
British Columbia Cancer Agency Branch - Vancover
Oslo University Hospital HE - Oslo
Fundacio Clinic - Barcelona
International Classification:
C40B 30/04
US Classification:
506 9
Abstract:
Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.
Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas
Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas
US Patent:
2007010, May 10, 2007
Filed:
Jul 25, 2006
Appl. No.:
11/493387
Inventors:
Louis Staudt - Silver Spring MD, US
George Wright - Rockville MD, US
Sandeep Dave - Washington DC, US
Bruce Tan - Baltimore MD, US
John Powell - Ijamsville MD, US
Wyndham Wilson - Washington DC, US
Elaine Jaffe - Great Falls VA, US
Wing Chan - Omaha NE, US
Timothy Greiner - Council Bluffs IA, US
Dennis Weisenburger - Elkhom NE, US
James Armitage - Omaha NE, US
Kai Fu - Omaha NE, US
Richard Fisher - Pittsford NY, US
Lisa Rimsza - Tucson AZ, US
Thomas Miller - Tucson AZ, US
Thomas Grogan - Tucson AZ, US
Elias Campo - Barcelona, ES
Silvia Bea - Sabadell, ES
Itziar Salaverria - Barcelona, ES
Armando Lopez-Guillermo - Barcelona, ES
Emili Montserrat - Barcelona, ES
Victor Moreno - Barcelona, ES
Andreas Zettl - Wurzburg, DE
German Ott - Wurzburg, DE
Hans-Konrad Muller-Hermelink - Wuerzburg, DE
Andreas Rosenwald - Wuerzburg, DE
Julie Vose - Omaha NE, US
Randy Gascoyne - North Vancouver, CA
Joseph Connors - Vancouver, CA
Erlend Smeland - Oslo, NO
Stein Kvaloy - Oslo, NO
Harald Holte - Oslo, NO
Jan Delabie - Oslo, NO
T. Andrew Lister - London, GB
George Wright - Rockville MD, US
Sandeep Dave - Washington DC, US
Bruce Tan - Baltimore MD, US
John Powell - Ijamsville MD, US
Wyndham Wilson - Washington DC, US
Elaine Jaffe - Great Falls VA, US
Wing Chan - Omaha NE, US
Timothy Greiner - Council Bluffs IA, US
Dennis Weisenburger - Elkhom NE, US
James Armitage - Omaha NE, US
Kai Fu - Omaha NE, US
Richard Fisher - Pittsford NY, US
Lisa Rimsza - Tucson AZ, US
Thomas Miller - Tucson AZ, US
Thomas Grogan - Tucson AZ, US
Elias Campo - Barcelona, ES
Silvia Bea - Sabadell, ES
Itziar Salaverria - Barcelona, ES
Armando Lopez-Guillermo - Barcelona, ES
Emili Montserrat - Barcelona, ES
Victor Moreno - Barcelona, ES
Andreas Zettl - Wurzburg, DE
German Ott - Wurzburg, DE
Hans-Konrad Muller-Hermelink - Wuerzburg, DE
Andreas Rosenwald - Wuerzburg, DE
Julie Vose - Omaha NE, US
Randy Gascoyne - North Vancouver, CA
Joseph Connors - Vancouver, CA
Erlend Smeland - Oslo, NO
Stein Kvaloy - Oslo, NO
Harald Holte - Oslo, NO
Jan Delabie - Oslo, NO
T. Andrew Lister - London, GB
International Classification:
C12Q 1/68, G06F 19/00
US Classification:
435006000, 702020000
Abstract:
Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.